Current Oncology Reports

, Volume 1, Issue 2, pp 105–109 | Cite as

Concurrent chemoradiotherapy in head and neck cancer

  • Susan G. Urba
Article

Abstract

Historically, patients with unresectable head and neck cancer have been treated with definitive radiation therapy alone. In recent years, numerous trials have assessed the role of concurrent chemoradiation for these patients. Many of the larger, more recent trials are summarized here, with particular emphasis on the effect of combined therapy on survival and toxicity. Most of the trials have demonstrated modest benefit or a trend toward benefit in survival, progression-free survival, or local control in patients treated with concurrent chemoradiation. However, nearly every trial also showed increased toxicity with the more aggressive regimens. Two meta-analyses also show a small but significant improvement in survival and increased toxicity from a concurrent treatment approach. Therefore, patients should be well selected by their physicians to be able to tolerate the side effects of combined-modality therapy and must be well informed of the pros and cons of concurrent chemoradiation during the decision-making process.

References and Recommended Reading

  1. 1.
    Sanchiz F, Milla A, Toner J, et al.: Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990, 19:1347–1350.PubMedGoogle Scholar
  2. 2.
    Brownman GP, Cripps C, Hodson I, et al.: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994, 12:2648–2653.Google Scholar
  3. 3.
    Bachaud JM, Cohen-Jonathon E, Alzieu G: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996, 36:999–1004.PubMedCrossRefGoogle Scholar
  4. 4.
    Haffty BG, Son YH, Papac R, et al.: Chemotherapy as an adjunct to radiation therapy in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials. J Clin Oncol 1997, 15:268–276.PubMedGoogle Scholar
  5. 5.
    Al-Sarraf M, LeBlanc M, Giri PG, et al.: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998, 16:1310–1317. This large multicenter study comparing radiotherapy with chemoradiotherapy for patients with nasopharyngeal cancer changed the standard of care in the United States for these patients.PubMedGoogle Scholar
  6. 6.
    Adelstein DJ, Saxton JP, Lavertu P, et al.: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997, 19:567–575.PubMedCrossRefGoogle Scholar
  7. 7.
    Adelstein DJ, Lavertu P, Saxton JP, et al.: Long term results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in squamous cell head and neck cancer [abstract]. Proc ASCO 1999, 18:394a.Google Scholar
  8. 8.
    Wendt TG, Grabenbauer GG, Rodel CM, et al.: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998, 16:1318–1324.PubMedGoogle Scholar
  9. 9.
    Brizel DM, Albers ME, Fisher SR, et al.: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338:1798–1804. This trial used a regimen of hyperfractionated radiation combined with concurrent chemotherapy and represents an attempt to design an aggressive treatment regimen both by adding chemotherapy and intensifying the radiation design.PubMedCrossRefGoogle Scholar
  10. 10.
    Calais G, Alfonsi M, Bardet E, et al.: Randomized study comparing radiation alone versus radiation with concomitant chemotherapy in stage III and IV oropharynx carcinoma: preliminary results of the 94.01 study from the French Group of Radiation Oncology for Head and Neck Cancer [abstract]. Proc ASCO 1998, 17:385a.Google Scholar
  11. 11.
    Merlano M, Benasso M, Corvo R, et al.: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996, 88:583–589. This large study has a long follow-up and presents a slightly different approach to concurrent chemoradiation by using a rapidly alternating regimen of chemotherapy and radiation that resulted in several improved parameters of survival and did not increase the severity of mucositis induced by radiation alone.PubMedCrossRefGoogle Scholar
  12. 12.
    El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J Clin Oncol 1996, 14:838–847. This meta-analysis demonstrates a small but significant benefit for patients treated with chemotherapy in combination with definitive therapy; the benefit is especially apparent with the concurrent treatment approach. The paper is well-written, making the statistics relatively easy to understand.PubMedGoogle Scholar
  13. 13.
    Bourhis J, Pignon JP, Designe L, et al.: Meta-analysis of chemotherapy in head and neck cancer: loco-regional treatment vs same treatment + chemotherapy [abstract]. Proc ASCO 1998, 17:386a. This meta-analysis has unfortunately only been published in abstract form to date, but the analysis was extremely thorough and meticulous, and the data appear to be as reliable as possible for a metaanalysis because of the updating of individual patient data done before the analysis.Google Scholar

Copyright information

© Current Science Inc 1999

Authors and Affiliations

  • Susan G. Urba
    • 1
  1. 1.University of Michigan Comprehensive Cancer CenterAnn ArborUSA

Personalised recommendations